NCM
ELDN icon

Nantahala Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Nantahala Capital Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,141,237
Closed -$2.96M – 162
2025
Q3 		$2.96M Hold
1,141,237
– – 0.1% 122
2025
Q2 		$3.09M Hold
1,141,237
– – 0.12% 114
2025
Q1 		$3.87M Sell
1,141,237
-6,709
-0.6% -$27.6K 0.15% 83
2024
Q4 		$4.73M Buy
1,147,946
+547,946
+91% +$2.16M 0.2% 83
2024
Q3 		$1.49M Hold
600,000
– – 0.08% 106
2024
Q2 		$1.58M Buy
+600,000
New +$1.43M 0.09% 96

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Nantahala Capital Management's ELDN Position: Q4 2025 in Review

Nantahala Capital Management sold out of Eledon Pharmaceuticals (ELDN) in Q4 2025, closing a stake of 1,141,237 shares — an estimated $2.96M sold.

Nantahala Capital Management first reported a position in ELDN in Q2 2024 and held it in 6 quarters. The position peaked at $4.73M in Q4 2024. 95 funds tracked by Wall St. Rank hold ELDN as of Q4 2025.

  • Nantahala Capital Management reported no remaining Eledon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Nantahala Capital Management sold 1,141,237 Eledon Pharmaceuticals shares in Q4 2025, an estimated $2.96M.
  • Nantahala Capital Management first reported a position in Eledon Pharmaceuticals in Q2 2024 and held it in 6 quarters.
  • Nantahala Capital Management's Eledon Pharmaceuticals position peaked at $4.73M in Q4 2024.
  • 95 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2025.

Based on Nantahala Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.